To Grow the Biomaterials Industry, "Support Mass Production Beyond Technology Development"
KoreaBIO Releases Policy Recommendations Report on Biomaterials
Proposes Policy Initiatives, Including Expanded Demonstration and Mass-Production Infrastructure
A recommendation has been made to strengthen the industrialization support system that connects research and development (R&D) achievements to actual product manufacturing and market entry, in order to enhance the competitiveness of Korea's biomaterials industry.
On November 19, the Korea Biotechnology Industry Organization (KoreaBIO) published a report titled "Paradigm Shift and Policy Recommendations for a Sustainable Biomaterials Industry," analyzing domestic and international trends in the biomaterials industry and case studies of major companies.
Biomaterials are materials developed using biological resources such as plants, microorganisms, and proteins, and are used across various industries, including food, cosmetics, and agriculture. Recently, advances in artificial intelligence (AI), synthetic biology, and biomanufacturing technologies have driven technological innovation throughout the entire process, from material development to production.
The report found that, for the sustained growth of Korea's biomaterials industry, support for commercialization linked to actual industry demand is needed, beyond support focused on technology development. It noted that, although support for technology development and commercialization has expanded, companies still face difficulties in validating the materials they develop, establishing mass-production systems, and entering the market.
To address these challenges, the report proposed six major policy initiatives: ▲standardizing biomaterial raw materials and establishing supply chains; ▲enhancing an industrialization support system based on market demand; ▲expanding infrastructure for demonstration and production scale-up; ▲improving regulatory and evaluation frameworks for new types of biomaterials; ▲building an AI-based innovation ecosystem for biomaterials; and △fostering investment and the industrial ecosystem.
In particular, the report emphasized the need to expand collaborative R&D and proof-of-concept (PoC) projects involving companies that will use the materials from the early stages of technology development. The goal is to establish a step-by-step support system that carries developed materials from performance validation through mass production and product development, connecting research outcomes to actual business opportunities.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
"Biomaterials have growing potential for use in various industries, including food, cosmetics, and agriculture, and advances in AI and biomanufacturing technologies are expanding industrial opportunities," said Oh Ki-hwan, head of the Bioeconomy Research Center at the Korea Biotechnology Industry Organization. "Policy efforts are needed to link collaboration with companies that will use the materials, demonstration and scale-up infrastructure, regulatory support, and investment support, so that Korean companies can turn the technologies they have developed into actual products and businesses."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.